Related Articles
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists:
AbstractBackgroundWhile cardiovascular benefits of tirzepatide, a glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes mellitus (T2DM),…
What for Worsening Heart Failure Events
The clinical course of patients with heart failure (HF) is notable for periods of stability interrupted by episodes of worsening signs and symptoms of HF…
Clinical and financial implications of inpatient and outpatient management of worsening heart failure
Inpatient and outpatient management of worsening heart failure. ED, emergency department; HF, heart failure; IV, intravenous; WHF, worsening heart failure.
Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead | Circulation: Heart Failure
The Get With the Guidelines-Heart Failure program was developed in 2005 with the goal of bringing evidence-based guidelines in heart failure management into widespread clinical…
Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead | Circulation: Heart Failure
The Get With the Guidelines-Heart Failure program was developed in 2005 with the goal of bringing evidence-based guidelines in heart failure management into widespread clinical…
Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead | Circulation: Heart Failure
The Get With the Guidelines-Heart Failure program was developed in 2005 with the goal of bringing evidence-based guidelines in heart failure management into widespread clinical…
Prescription patterns in management of Heart failure and its association with re-admissions: A retrospective analysis.
: AHA/ACC/HFSA recently added SGLT2i in addition to RAASi, Beta-blockers and MRAs to form the 4 pillars of Guideline-directed Medical Therapy (GDMT) for management of…
What for Worsening Heart Failure Events
The clinical course of patients with heart failure (HF) is notable for periods of stability interrupted by episodes of worsening signs and symptoms of HF…
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. ARNI, angiotensin receptor/neprilysin inhibitor; CRT, cardiac resynchronization the…
Visit-to-Visit Variability in Lipid Levels and Risk of Incident Heart Failure in Adults With Type 2 Diabetes
OBJECTIVE. Limited data exist on the relation between long-term variability in blood lipid fractions and incident heart failure (HF) in the setting of type